Implementation Science to Advance HIV Prevention, Treatment, and Care (R61/R33 Clinical Trial Optional)

The summary for the Implementation Science to Advance HIV Prevention, Treatment, and Care (R61/R33 Clinical Trial Optional) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.

Implementation Science to Advance HIV Prevention, Treatment, and Care (R61/R33 Clinical Trial Optional): The purpose of this notice of funding opportunity (NOFO) is to support implementation research on strategies to improve the uptake, implementation, sustainment, scale and/or spread of evidence-based prevention, treatment, and care interventions in communities in the U.S. significantly impacted by HIV. Projects should be large in scale with high potential for research and public health impact. Specifically, large single site studies, multi-site studies, and comparative studies are encouraged as scientifically appropriate.

Federal Grant Title:	Implementation Science to Advance HIV Prevention, Treatment, and Care (R61/R33 Clinical Trial Optional)
Federal Agency Name:	National Institutes of Health (HHS-NIH11)
Grant Categories:	Health
Type of Opportunity:	Discretionary
Funding Opportunity Number:	RFA-AI-27-018
Type of Funding:	Grant
CFDA Numbers:	93.121, 93.233, 93.242, 93.273, 93.279, 93.307, 93.310, 93.313, 93.361, 93.393, 93.394, 93.399, 93.837, 93.838, 93.839, 93.840, 93.846, 93.847, 93.855, 93.865, 93.866, 93.879
CFDA Descriptions:	Information not provided
Current Application Deadline:	June 20th, 2029
Original Application Deadline:	June 20th, 2029
Posted Date:	October 6th, 2026
Creation Date:	October 6th, 2026
Archive Date:	August 20th, 2029
Total Program Funding:	$7,000,000
Maximum Federal Grant Award:
Minimum Federal Grant Award:
Expected Number of Awards:	10
Cost Sharing or Matching:	No
Last Updated:	October 6th, 2026

Applicants Eligible for this Grant: State governments - County governments - City or township governments - Special district governments - Independent school districts - Public and State controlled institutions of higher education - Native American tribal governments (Federally recognized) - Public housing authorities/Indian housing authorities - Native American tribal organizations (other than Federally recognized tribal governments) - Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education - Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education - Private institutions of higher education - For-profit organizations other than small businesses - Small businesses - Others (see text field entitled "Additional Information on Eligibility" for clarification.)
Additional Information on Eligibility: Other Eligible ApplicantsIndian/Native American Tribal Governments (Other than Federally Recognized);Eligible Agencies of the Federal Government;U.S. Territory or Possession;Faith-based or Community-based Organizations;Regional Organizations;Non-domestic (non-U.S.) Entities (Foreign Institutions).
Grant Announcement Contact: National Institute of Allergy and Infectious Diseases (NIAID)
[email protected]
[email protected]
Similar Government Grants: • Collaborative Program Grant for Interdisciplinary Teams (RM1 Clinical Trial Optional); • Specialized Programs of Research Excellence (SPOREs) in Human Cancers for Years 2027, 2028...; • HEAL Initiative: Whole Joint Health Program (R61/R33 Clinical Trial Required); • NIH Brain Development Cohorts (NBDC) and Population Assessment of Tobacco and Health ...; • Grants for Early Medical/Surgical Specialists' Transition to Aging Research (GEMSSTAR) (R0...; • Epidemiological and Behavioral Research in Oral Health; • Metagenomic Analyses of the Oral Microbiome; • Phase Iii Clinical Trials in Oral Infectious Diseases
More Grants from the National Institutes of Health: • Specialized Alcohol Research Centers (P50 Clinical trial Optional); • Limited Competition: Biospecimen Banks to support NCI National Clinical Trials Network Bio...; • Single Source for the Continuation of the Physiology of the Weight Reduced State (POWERS) ...; • Assessing the Feasibility of Incorporating Mechanisms in Multi-site Clinical Trials of Min...; • Early-Onset Cancers: Investigating Etiology, Mechanisms, and Early Detection Strategies (R...